Karyopharm Therapeutics Stock Price History

KPTI Stock

USD 0.85 0.07 8.97%

Below is the normalized historical share price chart for Karyopharm Therapeutics extending back to November 06, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Karyopharm Therapeutics stands at 0.85, as last reported on the 23rd of November, with the highest price reaching 0.87 and the lowest price hitting 0.77 during the day.

IPO Date

6th of November 2013

200 Day MA

1.013

50 Day MA

0.8271

Beta

0.154

Yuan Drop

Covid

If you're considering investing in Karyopharm Stock, it is important to understand the factors that can impact its price. Karyopharm Therapeutics is very risky at the moment. Karyopharm Therapeutics has Sharpe Ratio of 0.0351, which conveys that the firm had a 0.0351% return per unit of risk over the last 3 months. We have found thirty technical indicators for Karyopharm Therapeutics, which you can use to evaluate the volatility of the firm. Please verify Karyopharm Therapeutics' Downside Deviation of 4.23, mean deviation of 3.39, and Risk Adjusted Performance of 0.0437 to check out if the risk estimate we provide is consistent with the expected return of 0.18%.

As of now, Karyopharm Therapeutics' Common Stock Shares Outstanding is increasing as compared to previous years. The Karyopharm Therapeutics' current Common Stock Total Equity is estimated to increase to about 14.5 K, while Total Stockholder Equity is forecasted to increase to (129.4 M). . The Karyopharm Therapeutics' current Price Earnings To Growth Ratio is estimated to increase to 0.02, while Price To Sales Ratio is projected to decrease to 0.64. Karyopharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0351

Best Portfolio	Best Equity
Good Returns
Average Returns
Small Returns			KPTI
Cash	Small Risk	Average Risk	High Risk	Huge Risk
Negative Returns

Estimated Market Risk

5.19

actual daily

54% of assets are more volatile

Expected Return

0.18

actual daily

97% of assets have higher returns

Risk-Adjusted Return

0.04

actual daily

98% of assets perform better

Based on monthly moving average Karyopharm Therapeutics is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Karyopharm Therapeutics by adding it to a well-diversified portfolio.

Price Book

12.0484

Enterprise Value Ebitda

(1.85)

Price Sales

0.7134

Shares Float

113.9 M

Wall Street Target Price

4.5

Karyopharm Therapeutics Stock Price History Chart

There are several ways to analyze Karyopharm Stock price data. The simplest method is using a basic Karyopharm candlestick price chart, which shows Karyopharm Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Highest Price	October 31, 2024	0.99
Lowest Price	September 23, 2024	0.7

Karyopharm Therapeutics November 23, 2024 Stock Price Synopsis

Various analyses of Karyopharm Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Karyopharm Stock. It can be used to describe the percentage change in the price of Karyopharm Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Karyopharm Stock.

	Karyopharm Therapeutics Price Action Indicator	0.06
	Karyopharm Therapeutics Price Daily Balance Of Power	0.70
	Karyopharm Therapeutics Price Rate Of Daily Change	1.09

Karyopharm Therapeutics November 23, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Karyopharm Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Karyopharm Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Karyopharm Stock and then apply it to test your longer-term investment strategies against Karyopharm.

Karyopharm Stock Price History Data

The price series of Karyopharm Therapeutics for the period between Sun, Aug 25, 2024 and Sat, Nov 23, 2024 has a statistical range of 0.29 with a coefficient of variation of 8.17. The daily prices for the period are spread out with arithmetic mean of 0.81. The median price for the last 90 days is 0.83.

	Open	High	Low	Close	Volume
11/23/2024	0.77	0.87	0.77	0.85
11/22/2024	0.77	0.87	0.77	0.85	518,398
11/21/2024	0.76	0.80	0.76	0.78	282,431
11/20/2024	0.77	0.79	0.76	0.78	367,489
11/19/2024	0.78	0.79	0.75	0.77	667,281
11/18/2024	0.83	0.86	0.78	0.79	241,575
11/15/2024	0.84	0.89	0.80	0.81	843,668
11/14/2024	0.89	0.89	0.83	0.84	395,566
11/13/2024	0.90	0.92	0.85	0.87	511,923
11/12/2024	0.92	0.95	0.88	0.90	542,960
11/11/2024	0.88	0.93	0.88	0.92	928,818
11/08/2024	0.88	0.92	0.86	0.88	980,812
11/07/2024	0.89	0.94	0.87	0.88	1,306,452
11/06/2024	0.85	0.93	0.85	0.89	1,078,020
11/05/2024	0.91	0.93	0.85	0.85	841,055
11/04/2024	0.92	0.95	0.91	0.93	428,923
11/01/2024	0.99	1.02	0.88	0.90	1,703,019
10/31/2024	0.90	1.13	0.87	0.99	8,385,352
10/30/2024	0.86	0.89	0.84	0.84	353,511
10/29/2024	0.88	0.90	0.85	0.85	316,392
10/28/2024	0.83	0.90	0.83	0.90	580,856
10/25/2024	0.83	0.84	0.82	0.83	266,800
10/24/2024	0.85	0.86	0.81	0.82	359,515
10/23/2024	0.86	0.86	0.83	0.85	256,166
10/22/2024	0.84	0.87	0.83	0.85	218,955
10/21/2024	0.85	0.89	0.84	0.85	145,220
10/18/2024	0.83	0.89	0.83	0.87	231,213
10/17/2024	0.85	0.87	0.84	0.85	150,237
10/16/2024	0.83	0.86	0.82	0.85	346,784
10/15/2024	0.85	0.88	0.83	0.84	215,585
10/14/2024	0.87	0.87	0.84	0.85	317,441
10/11/2024	0.84	0.87	0.84	0.86	170,586
10/10/2024	0.84	0.86	0.82	0.85	520,630
10/09/2024	0.84	0.87	0.82	0.85	579,631
10/08/2024	0.87	0.88	0.84	0.84	457,302
10/07/2024	0.90	0.90	0.85	0.87	740,767
10/04/2024	0.88	0.93	0.84	0.89	686,040
10/03/2024	0.88	0.93	0.84	0.88	1,802,952
10/02/2024	0.75	0.94	0.74	0.88	3,067,777
10/01/2024	0.83	0.83	0.74	0.76	1,217,739
09/30/2024	0.73	0.83	0.72	0.83	1,837,447
09/27/2024	0.72	0.73	0.69	0.72	933,121
09/26/2024	0.70	0.72	0.68	0.71	934,438
09/25/2024	0.71	0.73	0.68	0.70	1,417,417
09/24/2024	0.70	0.71	0.68	0.70	640,335
09/23/2024	0.74	0.75	0.69	0.70	671,782
09/20/2024	0.74	0.75	0.72	0.74	464,233
09/19/2024	0.74	0.76	0.73	0.74	453,933
09/18/2024	0.78	0.78	0.74	0.74	343,722
09/17/2024	0.77	0.78	0.75	0.75	363,759
09/16/2024	0.77	0.80	0.76	0.77	413,975
09/13/2024	0.73	0.77	0.73	0.76	646,513
09/12/2024	0.74	0.76	0.72	0.74	448,115
09/11/2024	0.73	0.75	0.71	0.74	341,915
09/10/2024	0.74	0.75	0.71	0.72	290,559
09/09/2024	0.73	0.77	0.73	0.74	319,236
09/06/2024	0.79	0.80	0.73	0.73	497,042
09/05/2024	0.70	0.80	0.69	0.80	1,121,333
09/04/2024	0.73	0.74	0.69	0.71	504,125
09/03/2024	0.74	0.77	0.71	0.72	596,482
08/30/2024	0.77	0.79	0.75	0.76	481,269

About Karyopharm Therapeutics Stock history

Karyopharm Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Karyopharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Karyopharm Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Karyopharm Therapeutics stock prices may prove useful in developing a viable investing in Karyopharm Therapeutics

	Last Reported	Projected for Next Year
Common Stock Shares Outstanding	114.2 M	119.9 M
Net Loss	-148.8 M	-156.2 M

Karyopharm Therapeutics Quarterly Net Working Capital

123.26 Million

Karyopharm Therapeutics Stock Technical Analysis

Karyopharm Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Volatility Indicators

View

Value Movement

View

A focus of Karyopharm Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Karyopharm Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio Comparator Now

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account

All Next

Launch Module

Karyopharm Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Karyopharm Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Karyopharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Karyopharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

	Risk Adjusted Performance	0.0437
	Jensen Alpha	0.0901
	Total Risk Alpha	(0.59)
	Sortino Ratio	0.0252
	Treynor Ratio	0.1999

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Complementary Tools for Karyopharm Stock analysis

When running Karyopharm Therapeutics' price analysis, check to measure Karyopharm Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Karyopharm Therapeutics is operating at the current time. Most of Karyopharm Therapeutics' value examination focuses on studying past and present price action to predict the probability of Karyopharm Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Karyopharm Therapeutics' price. Additionally, you may evaluate how the addition of Karyopharm Therapeutics to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Bonds Directory Find actively traded corporate debentures issued by US companies
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Karyopharm Therapeutics Stock Price History

Sharpe Ratio = 0.0351

Estimated Market Risk

Expected Return

Risk-Adjusted Return

Karyopharm Therapeutics Stock Price History Chart

Karyopharm Therapeutics November 23, 2024 Stock Price Synopsis

Karyopharm Therapeutics November 23, 2024 Stock Price Analysis

Karyopharm Stock Price History Data

About Karyopharm Therapeutics Stock history

Karyopharm Therapeutics Quarterly Net Working Capital

123.26 Million

Karyopharm Therapeutics Stock Technical Analysis

Did you try this?

Run Portfolio Comparator Now

Portfolio Comparator

Karyopharm Therapeutics Technical and Predictive Indicators

Complementary Tools for Karyopharm Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY